Buy 5 High Dividend-Paying Giants to Stay Safe Amid Volatile Markets

Amidst volatile market conditions in 2025 driven by overstretched valuations, inflation, and geopolitical concerns, Zacks Investment Research suggests investing in high-dividend-paying stocks with strong financials. The report highlights five companies: Philip Morris International (PM), benefiting from smoke-free products with expected revenue and earnings growth of 8.1% and 13.7% respectively; CVS Health (CVS), focusing on technology and cost reduction with expected revenue and earnings growth of 3.7% and 12.6% respectively; Energy Transfer LP (ET), leveraging fee-based contracts with expected revenue and earnings growth of 18.2% and 12.5% respectively; GSK plc (GSK), driven by specialty medicines with expected revenue and earnings growth of 5.1% and 6.7% respectively; and NatWest Group plc (NWG), experiencing growth across banking segments with expected revenue and earnings growth of 20.1% and 17.3% respectively.

Analysis

Wall Street is projected to experience continued volatility throughout 2025, driven by concerns including overstretched U.S. stock valuations, persistent inflation, weak economic indicators, geopolitical tensions, potential tariff and trade policy shifts, and uncertainty regarding Federal Reserve rate cuts, alongside fears of a near-term recession and the emergence of low-cost Chinese AI platforms. In this environment, the article advocates for a defensive investment posture, emphasizing high dividend-paying large-cap companies with strong financial positions and robust business models. Philip Morris International (PM), with a Zacks Rank #1, is highlighted for its strong pricing power and expanding smoke-free product portfolio, expecting 8.1% revenue and 13.7% earnings growth for the current year, with a 3.01% dividend yield and a 4.6% upward revision in current-year earnings estimates over the last 60 days. CVS Health Corp. (CVS), a Zacks Rank #2, is focusing on technological advancements for cost reduction and customer experience, anticipating 3.7% revenue and 12.6% earnings growth, a 4.34% dividend yield, and a 3.6% improvement in current-year earnings estimates in the past 30 days. Energy Transfer LP (ET), also Zacks Rank #2, benefits from long-term fee-based contracts (constituting 90% of earnings) and is projected for 18.2% revenue and 12.5% earnings growth, offering a significant 7.30% dividend yield, with current-year earnings estimates up 2.9% in the last 30 days. GSK plc (GSK), a Zacks Rank #2, shows strength in HIV and Vaccines, with its Specialty Medicines unit driving growth; it expects 5.1% revenue and 6.7% earnings growth, a 4.28% dividend yield, and a slight 0.7% increase in current-year earnings estimates over seven days. Finally, NatWest Group plc (NWG), a Zacks Rank #1, is demonstrating robust growth across its banking segments, with expected revenue and earnings growth of 20.1% and 17.3% respectively, a 5.41% dividend yield, and a notable 6.8% upward revision in current-year earnings estimates in the last 30 days. These firms are presented as stable options offering income streams during market fluctuations.

Key Decisions for Investors

• Given the anticipated market volatility and macroeconomic uncertainties in 2025, investors should consider reallocating towards or increasing exposure to high-quality, large-cap companies with consistent dividend payments to enhance portfolio stability and generate income.
• Evaluate the specific merits of Philip Morris (PM), CVS Health (CVS), Energy Transfer (ET), GSK plc (GSK), and NatWest Group (NWG), considering their individual growth prospects, positive earnings estimate revisions, and attractive dividend yields as outlined.
• Maintain a cautious outlook and monitor key market drivers such as inflation trends, Federal Reserve policy decisions, geopolitical developments, and trade policies, as these factors will continue to influence market stability and the attractiveness of defensive, dividend-focused strategies.